Treatment Pattern and Economic Burden of Refractory Gastroesophageal Reflux Disease Patients in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Susan | - |
dc.contributor.author | Kwon, Jin-Won | - |
dc.contributor.author | Park, Joong-Min | - |
dc.contributor.author | Park, Sungsoo | - |
dc.contributor.author | Seo, Kyung Won | - |
dc.date.accessioned | 2021-08-31T04:45:32Z | - |
dc.date.available | 2021-08-31T04:45:32Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2020-04 | - |
dc.identifier.issn | 2093-0879 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/56756 | - |
dc.description.abstract | Background/Aims The prevalence of gastroesophageal reflux disease (GERD) has increased in Korea, and the economic burden of this chronic disease is substantial. We aim to investigate the treatment pattern and economic burden in Korea of refractory GERD requiring long-term use of proton pump inhibitors (PPIs). Methods We conducted a cross-sectional analysis of nationally representative sample data obtained from 2012 to 2016 and provided by the Health Insurance Review and Assessment Service. The participants were 86 936 in the medication group and 40 in the surgery group. Age- and sex-standardized prevalence of refractory GERD requiring PPIs medication for more than 12 weeks were analyzed. Generalized linear models were used to estimate cost ratios for comparing the medical costs of the surgery and medication groups after adjustment for demographics and comorbidity. Results The prevalence of refractory GERD increased from 1.2% in 2012 to 1.9% in 2016, and the estimated total number of GERD patients increased from 402 000 to 736 000 during this time period. The medical expenditures of the surgery group within 90 days of antireflux surgery (ARS) were 16.9-fold higher compared to those of the medication group; the significant difference in medical costs between the 2 groups disappeared after 90 days post-surgery. Conclusions The prevalence of refractory GERD requiring long-term use of PPIs has been trending upwards recently. Nevertheless, ARS is very rarely performed. Considering the increasing medical costs of long-term PPI use, further cost-effectiveness analysis is needed to compare ARS and PPI therapy for the treatment of GERD in Korea. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC NEUROGASTROENTEROLOGY & MOTILITY | - |
dc.subject | PROTON PUMP INHIBITORS | - |
dc.subject | LAPAROSCOPIC NISSEN FUNDOPLICATION | - |
dc.subject | ANTIREFLUX SURGERY | - |
dc.subject | MEDICAL-MANAGEMENT | - |
dc.subject | COST-EFFECTIVENESS | - |
dc.subject | RISK-FACTORS | - |
dc.subject | PREVALENCE | - |
dc.subject | SYMPTOMS | - |
dc.subject | GUIDELINES | - |
dc.subject | DIAGNOSIS | - |
dc.title | Treatment Pattern and Economic Burden of Refractory Gastroesophageal Reflux Disease Patients in Korea | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Sungsoo | - |
dc.identifier.doi | 10.5056/jnm19050 | - |
dc.identifier.scopusid | 2-s2.0-85083452629 | - |
dc.identifier.wosid | 000523266700014 | - |
dc.identifier.bibliographicCitation | JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, v.26, no.2, pp.281 - 288 | - |
dc.relation.isPartOf | JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY | - |
dc.citation.title | JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY | - |
dc.citation.volume | 26 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 281 | - |
dc.citation.endPage | 288 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002584673 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.subject.keywordPlus | PROTON PUMP INHIBITORS | - |
dc.subject.keywordPlus | LAPAROSCOPIC NISSEN FUNDOPLICATION | - |
dc.subject.keywordPlus | ANTIREFLUX SURGERY | - |
dc.subject.keywordPlus | MEDICAL-MANAGEMENT | - |
dc.subject.keywordPlus | COST-EFFECTIVENESS | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordPlus | SYMPTOMS | - |
dc.subject.keywordPlus | GUIDELINES | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.subject.keywordAuthor | Fundoplication | - |
dc.subject.keywordAuthor | Gastroesophageal reflux | - |
dc.subject.keywordAuthor | Proton pump inhibitors | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.